A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Conditions:   Sarcoma;   Myxofibrosarcoma;   Undifferentiated Pleomorphic Sarcoma;   Alveolar Soft Part Sarcoma Interventions:   Procedure: Isolated Limb Infusion;   Drug: Pembrolizumab;   Drug: infusion of melphalan and dactinomycin Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials